Captrust Financial Advisors Cv Rx, Inc. Transaction History

Captrust Financial Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$11.67 - $33.01 $131,789 - $372,781	-11,293 Reduced 53.13%	9,963 $313,000
Q2 2023 Aug 14, 2023	BUY	$8.57 - $15.44 $182,163 - $328,192	21,256 New	21,256 $328,000
Q2 2022 Aug 16, 2022	SELL	$4.7 - $7.22 $756 - $1,162	-161 Reduced 21.44%	590 $4,000
Q1 2022 May 16, 2022	BUY	$5.62 - $12.37 $4,220 - $9,289	751 New	751 $4,000

14.4M

56.3K

41.8K

Ticker CVRX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,576,200
Market Cap $292M
Description
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.